- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2018
- Public Summary Document (PSD) March 2018 PBAC Meeting - PDF
- Public Summary Document (PSD) March 2018 PBAC Meeting - Word
Rituximab – March 2018
Rituximab: Solution for subcutaneous injection containing rituximab 1400 mg in 11.7 mL; MabThera® SC
Last updated
29 June 2018